Other OTC - Delayed Quote • USD
Kaleido Biosciences, Inc. (KLDO)
At close: 2:09 PM EDT
Breakdown
TTM
12/31/2021
12/31/2020
Total Revenue
1,104.0000
1,104.0000
975.0000
Operating Expense
88,771.0000
88,771.0000
79,849.0000
Operating Income
-87,667.0000
-87,667.0000
-78,874.0000
Net Non Operating Interest Income Expense
-2,766.0000
-2,766.0000
-2,553.0000
Other Income Expense
145.0000
145.0000
-193.0000
Pretax Income
-90,288.0000
-90,288.0000
-81,620.0000
Net Income Common Stockholders
-90,288.0000
-90,288.0000
-81,620.0000
Diluted NI Available to Com Stockholders
-90,288.0000
-90,288.0000
-81,620.0000
Basic EPS
-2.16
--
-2.44
Diluted EPS
-2.16
--
-2.44
Basic Average Shares
41,859.9930
--
33,450.2130
Diluted Average Shares
41,859.9930
--
33,450.2130
Total Operating Income as Reported
-87,667.0000
-87,667.0000
-78,874.0000
Total Expenses
88,771.0000
88,771.0000
79,849.0000
Net Income from Continuing & Discontinued Operation
-90,288.0000
-90,288.0000
-81,620.0000
Normalized Income
-90,288.0000
-90,288.0000
-81,620.0000
Interest Income
72.0000
72.0000
249.0000
Interest Expense
2,838.0000
2,838.0000
2,802.0000
Net Interest Income
-2,766.0000
-2,766.0000
-2,553.0000
EBIT
-87,450.0000
-87,450.0000
-78,818.0000
EBITDA
-85,092.0000
-85,092.0000
-76,995.0000
Reconciled Depreciation
2,358.0000
2,358.0000
1,823.0000
Net Income from Continuing Operation Net Minority Interest
-90,288.0000
-90,288.0000
-81,620.0000
Normalized EBITDA
-85,092.0000
-85,092.0000
-76,995.0000
12/31/2020 - 2/28/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TRDA Entrada Therapeutics, Inc.
12.43
-3.57%
DYAI Dyadic International, Inc.
1.5000
-0.66%
AVTE Aerovate Therapeutics, Inc.
21.20
-8.70%
AURA Aura Biosciences, Inc.
7.10
-1.66%
SEER Seer, Inc.
1.7700
-2.21%
PASG Passage Bio, Inc.
1.2400
+0.81%
AEZS Aeterna Zentaris Inc.
1.9700
-0.51%
LYRA Lyra Therapeutics, Inc.
5.23
+0.38%
ALEC Alector, Inc.
5.25
-1.69%
BCEL Atreca, Inc.
0.0850
+6.25%